|

Cladribine Subcutaneous Injection Clinical Trials

1 actively recruiting trial

Also known as: Cladribine Solution

Pipeline

Phase 2/3: 1

Top Sponsors

  • Institute of Psychiatry and Neurology, Warsaw1

Indications

  • Multiple Sclerosis, Secondary Progressive1
  • Multiple Sclerosis1

Other1 trial

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.